Publications

Publications

• Kumar GJ, Pawar SD, Pawar SR, et al. Process development for the total synthesis of the novel drug metabolite Carboxy toremifene as a standard reference material along with characterization and purity assessment for the Antidoping quality Control Purposes. Drug Test Anal. 2022; 1‐5. I.F.: 3.345

• MK Verma, S Roychowdhury, BD Sahu, A Mishra, KK Sethi*, CRISPR‐based point‐of‐care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes advanced for SARS‐CoV‐2 detection. Journal of Biochemical and Molecular Toxicology, e23113, 2022. I.F.: 3.568

• Trivedi MK, Panda P, Sethi KK, Gangwar M, Mondal SC, Jana S *. Solid and liquid state characterization of tetrahydrocurcumin using XRPD, FT-IR, DSC, TGA, LC-MS, GC-MS, NMR, and its biological activities. Journal of Pharmaceutical Analysis, 2020, 10, 334-345. I.F.: 14.026

• Sethi KK. Human Carbonic Anhydrase Inhibitors (hCAIs) a Druggable Target for Cancer Therapy. Editorial. EC Pharmacology and Toxicology, 4.4 (2017): 135-137.

• Trivedi MK, Dixit N, Panda P, Sethi KK, Jana S*. In-depth Investigation on Physicochemical and Thermal Properties of Magnesium (II) Gluconate Using Spectroscopic and Thermoanalytical Techniques. Journal of Pharmaceutical Analysis, 2017, 7, 332-337. I.F.: 14.026

• Trivedi MK, Panda P, Sethi KK, Jana S*. Liquid Chromatography Tandem Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy of Magnesium (II) Gluconate Solution. Journal of Solution Chemistry, 2017, 46, 896-907. I.F.: 2.0

• Trivedi MK, Sethi KK, Panda P, Jana S*. A comprehensive physicochemical, thermal, and spectroscopic characterization of zinc (II) chloride using X-ray diffraction, particle size distribution, differential scanning calorimetry, thermogravimetric analysis/differential thermogravimetric analysis, ultraviolet-visible, and Fourier transform-infrared spectroscopy. Int J Pharma Investig, 2017, 7, 33-44.

• Trivedi MK, Sethi KK, Panda P, Jana S*. Physicochemical, thermal, and spectroscopic characterization of sodium selenate using XRD, PSD, DSC, TGA/DTG, UV-vis, and FT- IR. Marmara Pharmaceutical Journal, 2017, 21(2), 311-318.

• Trivedi MK, Sethi KK, Panda P, Jana S*. Metabolite profiling of Withania somnifera roots hydroalcoholic extract using LC-MS, GC-MS and NMR spectroscopy. Chemistry and Biodiversity, 2017, 14, e1600280. I.F.: 2.745

• Sethi KK*, Nayak PK., Sarkar H, Verma SM. A rational approach towards the development of human carbonic anhydrase inhibitors as antiepileptic agent. Medicinal chemistry. 2016, 6, 405-410.

• Sethi KK*, Verma SM, Tanç M, Carta F, and Supuran CT. Carbonic Anhydrase Inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties. Bioorganic & Medicinal Chemistry, 2014, 22, 1586-1595. I.F.: 3.641

• Sethi KK* and Verma SM. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors. Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, 29, 571-581. I.F.: 5.756

•  Sethi KK*, Vullo D, Verma SM, Tanç M, Carta F, and Supuran CT. Carbonic Anhydrase Inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII,  IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalic anhydride moiety. Bioorganic & Medicinal Chemistry, 2013, 21, 5973-5982. I.F.: 3.641

• Sethi KK*, Verma SM, Tanç M, Carta F, and Supuran CT. Carbonic Anhydrase Inhibitors: Synthesis and Inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII withbenzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalic anhydride moiety. Bioorganic & Medicinal Chemistry, 2013, 21(17), 5168-5174. I.F.: 3.641

• Brijesh Patel, Verma SM *, and Sethi KK. 3D-QSAR and Docking studies of N-hydroxy 1,8-naphthyridine 2-one analogues as Ribonuclease H Inhibitors. Letters in Drug Design & Discovery, 2013, 10(9), 823-835. I.F.: 1.169

• Sethi KK* and Verma SM. Pharmacophore modeling and 3D QSAR studies of novel human carbonic anhydrase IX inhibitors. Letters in Drug Design & Discovery, 2013, 10, 808-816. I.F.: 1.169

• Verma SM, Saha A, Mishra R, and Sethi KK*. 3D-QSAR study of some heterocyclic sulfonamide analogs as hCAII inhibitors. Letters in Drug Design & Discovery, 2012, 9, 581-586. I.F.: 1.169

• Mishra R *, Ganguly S, Sethi KK, Mazumder PM. Synthesis and Anticonvulsant Activity of Some Novel 2-Methyl Imidazole Derivatives. Letters in Drug Design & Discovery, 2012, 9(4), 402-408. I.F.: 1.169

• Sethi KK*, Pichikala JN, Sahoo SK, Suresh P. Carbonic Anhydrase I and II inhibition with natural products: Caffeine and Piperine. Journal of Enzyme Inhibition and Medicinal Chemistry, 2012, 27, 97-100. I.F.: 5.756

• Sethi KK*, Verma SM, Kumar PM, Mishra R. Carbonic Anhydrase I and II inhibition with natural products: Leucas Cephalotes. Pharmacognosy Communication, 2011, 1, 40-45.

• Sethi KK*, Suresh P, and Mondal S. Carbonic Anhydrase I and II inhibition with natural products: Abrus Precatorius. Current Enzyme Inhibition, 2011, 7, 119-124.

• Sethi KK*, Verma SM, Prasanthi N, Annapurna MM. Synthesis, neurotoxicity, and anticonvulsant study of some benzothiazole analogs. Letters in Drug Design & Discovery, 2011, 8, 774-777. I.F.: 1.169.

• Hathi DK*, Bhatnagar SP, Sethi KK*. Development and Evaluation of Polyherbal Antidandruff Hail Oil. Pharmacognosy Journal. 2010, 2, 328-334. I.F.: 0.82

• Hathi DK*, Bhatnagar SP, Sethi KK*. Development and Evaluation of Polyherbal Antidandruff Hail Oil. Pharmacognosy Journal. 2010, 2, 328-334. I.F.: 0.82

• Sethi KK*, Verma SM, Prasanthi N, Sahoo SK, Parhi RN, Suresh P. 3D-QSAR study of Benzene Sulfonamides as human Carbonic Anhydrase II Inhibitor. Bioorganic and Medicinal Chemistry Letters, 2010, 20, 3089-3093. I.F.: 2.94

Patents

• ·Sethi KK, Verma SM. 4,5,6,7-tetrachloro-1,3-dioxoisoindolin-2-yl benzenesulfonamide derivatives. Ref. no.: E-2/2088/2013-KOL, Application no. 568/KOL/2013. Indian Patent office, at Kolkata, India. (Published)

• Sethi KK. Active human Carbonic Anhydrase Inhibitors (hCAIs) benzenesulfonamide compounds. Ref. no.: E-12/134/2021/KOL, Application no. 202131017895. Indian Patent office, at Kolkata, India. (Complete Specification Filed)

• Process to prepare octopamine sulfate. Patent Application No. 202231000058. Indian Patent office, at Kolkata, India. (Complete Specification Filed)

• Methods for preparation of Lutein from marigold flowers. Patent Application No. 202231062144. Indian Patent office, at Kolkata, India. (Complete Specification Filed)

Conference Attended 

• Kalyan K Sethi, Pramod Dewangan, N. Padma, S. M. Verma. Docking studies of N, N1-bis substituted aryl guanidine derivatives as NMDA receptor antagonists. 13th Association of Pharmaceutical Teachers of India National Convention, Bilaspur, 2008, Chattishgarh, India.

• Kalyan Kumar Sethi, Kamble Mahesh Gopichand, KM Abha Mishra, Akkewar Ashish Sunil. Economical scale-up process development for the high yield and high purity lutein from the waste natural product. International Symposium on Recent Trends and Future Opportunities in Pharmaceuticals. November 10-12, 2022. National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar - 160062, Punjab (INDIA)

• Sethi KK, Mishra KA, Verma SM, Vullo D, Carta F, Supuran CT. Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties. International Symposium on Recent Trends and Future Opportunities in Pharmaceuticals. November 10-12, 2022. National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar - 160062, Punjab (INDIA)